(Q36283411)

13 August 2017

1 reference

title

Autoimmune myocarditis and dilated cardiomyopathy: focus on cardiac autoantibodies (English)

1 reference

13 August 2017

1 reference

dilated cardiomyopathy

1 reference

based on heuristic

inferred from title

autoimmune myocarditis

1 reference

A L P Caforio

1

1 reference

13 August 2017

L Daliento

2

1 reference

13 August 2017

A Angelini

3

1 reference

13 August 2017

S Bottaro

4

1 reference

13 August 2017

A Vinci

5

1 reference

13 August 2017

G Dequal

6

1 reference

13 August 2017

F Tona

7

1 reference

13 August 2017

S Iliceto

8

1 reference

13 August 2017

G Thiene

9

1 reference

13 August 2017

W J McKenna

10

1 reference

13 August 2017

publication date

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

14

1 reference

13 August 2017

issue

9

1 reference

13 August 2017

page(s)

652-655

1 reference

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2193OA

Recognition and optimum management of myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2193OA

Dilated cardiomyopathy: learning to live with yourself.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2193OA

Defining criteria for autoimmune diseases (Witebsky's postulates revisited)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2193OA

Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2193OA

Familial clustering of autoimmune diseases in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2193OA

Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2193OA

Autoimmunity to alpha myosin in a subset of patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2193OA

Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2193OA

Antibody-mediated enhancement of calcium permeability in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2193OA

Beta-adrenoceptor antibodies and genetics in dilated cardiomyopathy-- An overview and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2193OA

Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2193OA

Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2193OA

Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2193OA

Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2193OA

10.1191/0961203305LU2193OA

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference